Lung Neoplasm — Trials

Lung Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

11,606 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 651–700 of 11,606 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07279935	Osimertinib Combined With Chemotherapy in Patients Who Had Distant Recurrence After Adjuvant Osimertinib for EGFRm Resectable SIB-IIIA NSCLC.(REVIVE)	recruiting	Phase 4	100	AstraZenecaINDUSTRY	1	Aug 27, 2026	clinicaltrials
NCT07630961	Phase I Study of JFI447 [68Ga]Ga-DFC413 and Comparison to FFG233 [68Ga]Ga-NNS309 in Patients With Solid Tumors	recruiting	Phase 1	66	Novartis PharmaceuticalsINDUSTRY	2	Aug 27, 2026